All news

Revvity beats with

Tradingpedia · · AI-summarised by FinFlash

Revvity shares rose 8.8% premarket after third-quarter adjusted earnings of

So What?

Life sciences tools demand looks firmer than feared, a positive read for peers; the November 13 Investor Day is the next catalyst.

Read original source

RVTY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.